These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2643197)

  • 1. Insulin antibodies and management of diabetes after total pancreatectomy.
    Ishikawa O; Ohhigashi H; Sasakuma F; Imaoka S; Hasegawa K; Okishio T; Sasaki Y; Koyama H; Iwanaga T
    Surgery; 1989 Jan; 105(1):57-64. PubMed ID: 2643197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum antibody-bound insulin as a measure of insulin antibodies in diabetic children.
    Koskinen P; Kaihola HL; Mäkelä AL; Irjala K; Knip M; Akerblom HK
    Diabetes Res; 1987 Sep; 6(1):15-9. PubMed ID: 3319351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating antibodies in diabetics treated with conventional and purified insulins.
    Klaff LJ; Vinik AI; Berelowitz M; Jackson WP
    S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the insulin antibody titre in severe form of diabetes mellitus].
    Pliats OM; Alekseev IuP
    Probl Endokrinol (Mosk); 1977; 23(3):12-4. PubMed ID: 887624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin antibodies and the control of diabetes.
    Dixon K; Exon PD; Malins JM
    Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for the immunoassay of insulin in the presence of insulin therapy-induced antibody.
    Davidson P; Deal RB
    J Lab Clin Med; 1976 Jun; 87(6):1050-6. PubMed ID: 778312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
    Kühnau J; Rüdiger H; Goetz K
    Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IRI in insulin-treated diabetics during a 24-hour period.
    Rasmussen SM; Heding LG; Parbst E; Volund A
    Diabetologia; 1975 Apr; 11(2):151-8. PubMed ID: 1149948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypoglycemia induced by insulin antibody during postoperative management with intravenous hyperalimentation--a case report and qualitative analysis of insulin antibody].
    Yasuda T; Ishikawa O; Ohigashi H; Furukawa H; Imaoka S; Iwanaga T; Sasakuma F
    Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):949-52. PubMed ID: 2507901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia.
    Goldman J; Baldwin D; Rubenstein AH; Klink DD; Blackard WG; Fisher LK; Roe TF; Schnure JJ
    J Clin Invest; 1979 May; 63(5):1050-9. PubMed ID: 447827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Late complications of diabetes mellitus-consequence of immunologic reactions?].
    Bemm H; Lohmann D
    Allerg Immunol (Leipz); 1974-1975; 20-21(1):15-20. PubMed ID: 4282823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin antibodies: reduction in various anti-insulin IgG subclasses with human insulin therapy.
    Kumar D
    Horm Metab Res; 1993 Jul; 25(7):360-4. PubMed ID: 8406321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of insulin antibodies.
    Kansal PC; Bandisode MS; Boshell BR
    Horm Metab Res; 1979 Mar; 11(3):187-9. PubMed ID: 447197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of insulin antibodies on insulin dose and diabetic control.
    Walford S; Allison SP; Reeves WG
    Diabetologia; 1982 Feb; 22(2):106-10. PubMed ID: 7037511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to insulin, pancreatic polypeptide, glucagon, and somatostatin in insulin-treated diabetics.
    Fitz-Patrick D; Patel YC
    J Clin Endocrinol Metab; 1981 May; 52(5):948-52. PubMed ID: 6112233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunogenicity of insulin preparations.
    Chance RE; Root MA; Galloway JA
    Acta Endocrinol Suppl (Copenh); 1976; 205():185-98. PubMed ID: 793278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free covalent aggregates of therapeutic insulin in blood of insulin-dependent diabetics.
    Robbins DC; Mead PM
    Diabetes; 1987 Feb; 36(2):147-51. PubMed ID: 3542642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.